|February 20, 2014|
|09:03 EDT||BIOL, SSYS||BIOLASE enters Reseller Agreement with Stratasys|
BIOLASE (BIOL) announced that it has entered into a Reseller Agreement with Stratasys (SSYS). Pursuant to the terms of the Agreement, BIOLASE will become a distributor of Stratasys' Objet30 OrthoDesk and a number of Design Series High End 3-D printers. The Objet30 OrthoDesk combines accurate and precise 3-D printing technology with a small footprint. It is easy to use, and includes specialized dental printing materials in convenient sealed cartridges. Dentists can fabricate stone models, orthodontic appliances, delivery and positioning trays, models for clear aligners, retainers and surgical guides on their desktop.
News For BIOL;SSYS From The Last 14 Days
|March 4, 2015|
|16:11 EDT||BIOL||BIOLASE reports Q4 adjusted EPS (6c), consensus (4c)|
Reports Q4 revenue $13.2M, consensus $14.9M.
|March 2, 2015|
|09:22 EDT||SSYS||On The Fly: Pre-market Movers |
UP AFTER EARNINGS: Amira Nature Foods (ANFI), up 8.6%... Stratasys (SSYS), up 3.6%... Magnum Hunter (MHR), up 3%. ALSO HIGHER: Mavenir Systems (MVNR), up 19.1% after Mitel (MITL) agrees to acquire Mavenir Systems for $560M... Athersys (ATHX), up 19.7% following license agreement and collaboration with Chugai... OHR Pharmaceutical (OHRP), up 11.4% following additional positive data from OHR-102 IMPACT study... NXP Semiconductors (NXPI), up 14% following merger agreement with Freescale Semiconductor (FSL). Freescale Semiconductor is up 9.1%... Mast Therapeutics (MSTX), up 7.7% following positive results from Vepoloxamer study. DOWN AFTER EARNINGS: JinkoSolar (JKS), down 4.7%... Scorpio Tankers (STNG), down 4.5%. ALSO LOWER: Lumber Liquidators (LL), down 24.2% following CBS' 60 Minutes says that the company is linked to health and safety violations... Aruba Networks (ARUN), down 1.7% after HP (HPQ) confirms deal to acquire Aruba Networks for $24.67... Pacira Pharmaceuticals (PCRX), down 14.4% after receiving complete response letter from FDA for sNDA in use of Exparel... 500.com (WBAI), down 14.4% after announcing that temporary suspension will adversely impact financial results.
|07:07 EDT||SSYS||Stratasys sees long-term adjusted net income as percent of sales 16%-21%|
Stratasys reiterated the following information regarding the company's long-term operating model: Annual organic revenue growth of at least 25%. Non-GAAP operating income as a percent of sales of 18% to 23%. Non-GAAP effective tax rate of 10% to 15%. Non-GAAP net income as a percent of sales of 16% to 21%.
|07:06 EDT||SSYS||Stratasys sees FY15 adjusted EPS $2.07-$2.24, consensus $2.12|
Subscribe for More Information
|07:05 EDT||SSYS||Stratasys reports Q4 adjusted EPS 48c, consensus 48c|
Reports Q4 revenue $217.1M, consensus $215.83M.
|06:02 EDT||BIOL||BIOLASE names David Dreyer CFO |
BIOLASE announced that it has David Dreyer as its CFO effective March 9. Dreyer replaces Frederick D. Furry, who resigned January 31 to pursue other opportunities. Dreyer most recently served as CFO of Patient Safety Technologies.
|February 25, 2015|
|10:04 EDT||SSYS||Stratasys volatility into Q4 and outlook |
Subscribe for More Information
|February 24, 2015|
|11:02 EDT||SSYS||Stratasys announces promotions within MakerBot unit|
Stratasys announced the transitioning of key executives and expanding responsibilities within its MakerBot business. Jenny Lawton, chief executive officer of MakerBot, will be promoted to executive VP Special Projects for Stratasys and will report directly to CEO David Reis in his capacity as the company’s chief business officer. Jonathan Jaglom, general manager from Stratasys Asia Pacific Japan, will be promoted to chief executive officer of MakerBot.